EVOX:NASDAQEvolution Global Acquisition Corp Analysis
Data as of 2026-04-01 - not real-time
$9.96
Latest Price
8/10Risk
Risk Level: High
Executive Summary
The stock is trading at roughly $9.96, just below its 20‑day moving average (≈$9.98) and marginally above the 200‑day average (≈$9.95), suggesting a neutral price bias. RSI sits in the mid‑30s, indicating modest oversold pressure, while the MACD remains bearish with the line below its signal, reinforcing short‑term downside momentum. Volume has been trending upward, yet daily turnover is low (≈1,000 shares) compared to its 10‑day average, hinting at limited liquidity. The market sentiment index reads “Extreme Greed,” which may be fueling speculative interest despite the lack of operational fundamentals.
Fundamentally, EVOX reports zero revenue, negative book value per share (‑$0.27), and a sizable debt balance of $241 k, with no cash generation and no dividend policy. As a shell company awaiting a merger, its valuation hinges entirely on the success of that transaction, making the current price appear overvalued relative to its asset base. The combination of negligible earnings, negative price‑to‑book, and high sector risk underscores a high overall risk profile.
Fundamentally, EVOX reports zero revenue, negative book value per share (‑$0.27), and a sizable debt balance of $241 k, with no cash generation and no dividend policy. As a shell company awaiting a merger, its valuation hinges entirely on the success of that transaction, making the current price appear overvalued relative to its asset base. The combination of negligible earnings, negative price‑to‑book, and high sector risk underscores a high overall risk profile.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price near immediate support level
- Bearish MACD alignment
- Increasing but thin trading volume
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- Absence of revenue or cash flow
- Negative book value and high debt
- Elevated sector and merger execution risk
Long Term
> 3 yearsCautious
Model confidence: 8/10
Key Factors
- Uncertain outcome of the pending business combination
- Persistent lack of operating fundamentals
- Continued exposure to shell‑company volatility
Key Metrics & Analysis
Financial Health
P/B Ratio-37.4
Op. Cash Flow$-526806
Industry P/E16.5
Technical Analysis
TrendNeutral
RSI34.6
Support$9.96
Resistance$10.03
MA 20$9.98
MA 50$10.00
MA 200$9.96
MACDBearish
VolumeIncreasing
Fear & Greed Index77.46
Valuation
GradeOvervalued
TypeBlend
Risk Assessment
Beta-0.00
Volatility1.15%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.